1. Home
  2. EML vs RGC Comparison

EML vs RGC Comparison

Compare EML & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EML
  • RGC
  • Stock Information
  • Founded
  • EML 1858
  • RGC 2014
  • Country
  • EML United States
  • RGC Hong Kong
  • Employees
  • EML N/A
  • RGC N/A
  • Industry
  • EML Industrial Machinery/Components
  • RGC Medicinal Chemicals and Botanical Products
  • Sector
  • EML Consumer Discretionary
  • RGC Health Care
  • Exchange
  • EML Nasdaq
  • RGC Nasdaq
  • Market Cap
  • EML 171.1M
  • RGC 171.1M
  • IPO Year
  • EML N/A
  • RGC 2021
  • Fundamental
  • Price
  • EML $29.76
  • RGC $6.69
  • Analyst Decision
  • EML
  • RGC
  • Analyst Count
  • EML 0
  • RGC 0
  • Target Price
  • EML N/A
  • RGC N/A
  • AVG Volume (30 Days)
  • EML 36.9K
  • RGC 207.6K
  • Earning Date
  • EML 08-06-2024
  • RGC 10-25-2024
  • Dividend Yield
  • EML 1.48%
  • RGC N/A
  • EPS Growth
  • EML 65.47
  • RGC N/A
  • EPS
  • EML 1.92
  • RGC N/A
  • Revenue
  • EML $273,702,675.00
  • RGC N/A
  • Revenue This Year
  • EML N/A
  • RGC N/A
  • Revenue Next Year
  • EML N/A
  • RGC N/A
  • P/E Ratio
  • EML $15.51
  • RGC N/A
  • Revenue Growth
  • EML N/A
  • RGC N/A
  • 52 Week Low
  • EML $16.10
  • RGC $3.03
  • 52 Week High
  • EML $35.78
  • RGC $32.44
  • Technical
  • Relative Strength Index (RSI)
  • EML 52.73
  • RGC 44.16
  • Support Level
  • EML $29.16
  • RGC $6.55
  • Resistance Level
  • EML $31.35
  • RGC $8.67
  • Average True Range (ATR)
  • EML 1.06
  • RGC 0.84
  • MACD
  • EML -0.06
  • RGC -0.28
  • Stochastic Oscillator
  • EML 38.37
  • RGC 5.19

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Share on Social Networks: